Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)2640-2643
Number of pages4
JournalBlood Advances
Volume4
Issue number12
DOIs
StatePublished - Jun 23 2020

Bibliographical note

Funding Information:
This work was supported by the National Institutes of Health, National Cancer Institute (P30 CA77598), utilizing the Biostatistics and Bioinformatics Core shared resource of the Masonic Cancer Center, and by the National Institutes of Health, National

Funding Information:
This work was supported by the National Institutes of Health, National Cancer Institute (P30 CA77598), utilizing the Biostatistics and Bioinformatics Core shared resource of the Masonic Cancer Center, and by the National Institutes of Health, National Center for Advancing Translational Sciences (UL1TR002494 and KL2TR002492).

Cite this